These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6309536)
21. Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule. Shaker N; Eldefrawi AT; Aguayo LG; Warnick JE; Albuquerque EX; Eldefrawi ME J Pharmacol Exp Ther; 1982 Jan; 220(1):172-7. PubMed ID: 6273528 [TBL] [Abstract][Full Text] [Related]
22. (+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Booth RG; Baldessarini RJ Brain Res; 1991 Aug; 557(1-2):349-52. PubMed ID: 1684130 [TBL] [Abstract][Full Text] [Related]
23. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Weber E; Sonders M; Quarum M; McLean S; Pou S; Keana JF Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8784-8. PubMed ID: 2877462 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque. Oswald RE; Michel L; Bigelow J Mol Pharmacol; 1986 Feb; 29(2):179-87. PubMed ID: 3951431 [TBL] [Abstract][Full Text] [Related]
25. Interaction of histrionicotoxin with the putative nicotinic acetylcholine receptor of the chick visual system. Betz H Neurosci Lett; 1982 Nov; 33(2):153-8. PubMed ID: 7155458 [TBL] [Abstract][Full Text] [Related]
26. Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Sonders MS; Keana JF; Weber E Trends Neurosci; 1988 Jan; 11(1):37-40. PubMed ID: 2469154 [No Abstract] [Full Text] [Related]
27. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists). Chang KJ; Hazum E; Cuatrecasas P Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and characterization of an affinity label for brain receptors to psychotomimetic benzomorphans: differentiation of sigma-type and phencyclidine receptors. Adams JT; Teal PM; Sonders MS; Tester B; Esherick JS; Scherz MW; Keana JF; Weber E Eur J Pharmacol; 1987 Oct; 142(1):61-71. PubMed ID: 2826177 [TBL] [Abstract][Full Text] [Related]
30. Sigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders. Itzhak Y; Stein I Life Sci; 1990; 47(13):1073-81. PubMed ID: 2172677 [TBL] [Abstract][Full Text] [Related]
32. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Hellewell SB; Bowen WD Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717 [TBL] [Abstract][Full Text] [Related]
33. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization. Souccar C; Varanda WA; Aronstam RS; Daly JW; Albuquerque EX Mol Pharmacol; 1984 May; 25(3):395-400. PubMed ID: 6328265 [TBL] [Abstract][Full Text] [Related]
34. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors. Weiland GA; Durkin JA; Henley JM; Simasko SM Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113 [TBL] [Abstract][Full Text] [Related]
35. Drug specificity of pharmacological dystonia. Matsumoto RR; Hemstreet MK; Lai NL; Thurkauf A; De Costa BR; Rice KC; Hellewell SB; Bowen WD; Walker JM Pharmacol Biochem Behav; 1990 May; 36(1):151-5. PubMed ID: 2161543 [TBL] [Abstract][Full Text] [Related]
36. Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Albuquerque EX; Tsai MC; Aronstam RS; Eldefrawi AT; Eldefrawi ME Mol Pharmacol; 1980 Sep; 18(2):167-78. PubMed ID: 6252436 [No Abstract] [Full Text] [Related]
37. Interaction of tricyclic antidepressants with the ionic channel of the acetylcholine receptor of Torpedo electric organ. Shaker N; Eldefrawi AT; Miller ER; Eldefrawi ME Mol Pharmacol; 1981 Nov; 20(3):511-8. PubMed ID: 6276711 [No Abstract] [Full Text] [Related]
38. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor. Costa AC; Swanson KL; Aracava Y; Aronstam RS; Albuquerque EX J Pharmacol Exp Ther; 1990 Feb; 252(2):507-16. PubMed ID: 1690291 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the interaction of phencyclidine and its derivatives with the ionic channel of the nicotinic receptor. Haring R; Theomy S; Kalir A; Sokolovsky M Arch Toxicol Suppl; 1983; 6():81-90. PubMed ID: 6312926 [TBL] [Abstract][Full Text] [Related]
40. Histrionicotoxins: effects on binding of radioligands for sodium, potassium, and calcium channels in brain membranes. Lovenberg T; Daly JW Neurochem Res; 1986 Nov; 11(11):1609-21. PubMed ID: 2446155 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]